Septic arthritis (peds): Difference between revisions

(Text replacement - "Ceftriaxone" to "Ceftriaxone")
 
(6 intermediate revisions by 3 users not shown)
Line 1: Line 1:
''This page is for <u>pediatric</u> patients; for adult patients see [[septic arthritis]].''
==Background==
==Background==
*Most often in patients < 3yo
*Most often in patients < 3yo
*MSSA and MRSA are most common causes in all age groups
*MSSA and MRSA are most common causes in all age groups
*Patients with sickle cell disease, rheumatoid arthritis, and inflammatory bowel disease are at increased risk
*Patients with sickle cell disease, rheumatoid arthritis, and inflammatory bowel disease are at increased risk


==Evaluation==
==Clinical Features==
 
*Neonates
*Neonates
**Do not appear ill
**Do not appear ill
Line 15: Line 14:
**CRP >20
**CRP >20
**WBC >12K
**WBC >12K
===Kocher Criteria===
*One point each
**Non-weight bearing on affected side
**ESR >40mm/hr
**Fever
**WBC >12,000
*Probability by points<ref> Kocher, MS, et al. Differentiating between septic arthritis and transient synovitis of the hip in children: an evidence-based clinical prediction algorithm. J Bone Joint Surg Am. 1999; 81 (12):1662–70.</ref>
**1 of 4 - 3%
**2 of 4 - 40%
**3 of 4 - 93%
**4 of 4 - 99%
==Work-Up==
*Labs
**CBC, ESR, CRP, , blood/throat cultures
*Arthrocentesis
**Cell count, gram stain, glucose, cultures


==Differential Diagnosis==
==Differential Diagnosis==
*Trauma
*[[Trauma]]
*[[Septic arthritis]]
*[[Septic arthritis]]
*[[Acute Rheumatic Fever]]
*[[Acute Rheumatic Fever]]
Line 52: Line 32:
*[[Osgood Schlatter Disease]]
*[[Osgood Schlatter Disease]]


==Treatment==
==Evaluation==
===Work-Up===
*Labs
**CBC, ESR, CRP, , blood/throat cultures
*[[Arthrocentesis]]
**Cell count, gram stain, glucose, cultures


===Kocher Criteria===
*One point each
**Non-weight bearing on affected side
**ESR >40mm/hr
**Fever
**WBC >12,000
*Probability by points<ref> Kocher, MS, et al. Differentiating between septic arthritis and transient synovitis of the hip in children: an evidence-based clinical prediction algorithm. J Bone Joint Surg Am. 1999; 81 (12):1662–70.</ref>
**1 of 4 - 3%
**2 of 4 - 40%
**3 of 4 - 93%
**4 of 4 - 99%
==Management==
#Joint drainage/wash out
#Joint drainage/wash out
#IV antibiotics
#IV [[antibiotics]]


{| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%"
{| cellspacing="1" cellpadding="3" border="0" bgcolor="#666666" width="100%"
Line 80: Line 78:
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | ''or''&nbsp;
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | ''or''&nbsp;
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[[[Ceftriaxone]]]], 50 milligrams/kg every 12 h
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Ceftriaxone]], 50 milligrams/kg every 12 h
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
|- class="font12" style="font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;"
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Gram-negative]] bacilli
| valign="top" bgcolor="#ffffff" class="font12" align="left" style="color: rgb(51, 51, 51); font-size: 12px; line-height: 17px; margin-top: 0px; margin-bottom: 9px; margin-left: 0px; margin-right: 0px;" | [[Gram-negative]] bacilli
Line 125: Line 123:


==Disposition==
==Disposition==
Admit
*Admit


==See Also==
==See Also==
*[[Septic Arthritis (General)]]
*[[Septic Arthritis (General)]]
*[[Arthrocentesis]]
*[[Arthrocentesis]]
*[[Septic arthritis of the hip (peds)]]


==References==
==References==
<references/>
<references/>


[[Category:Pediatrics]]
[[Category:Pediatrics]]
[[Category:Orthopedics]]
[[Category:Orthopedics]]
[[Category:ID]]
[[Category:ID]]

Latest revision as of 19:29, 22 October 2020

This page is for pediatric patients; for adult patients see septic arthritis.

Background

  • Most often in patients < 3yo
  • MSSA and MRSA are most common causes in all age groups
  • Patients with sickle cell disease, rheumatoid arthritis, and inflammatory bowel disease are at increased risk

Clinical Features

  • Neonates
    • Do not appear ill
    • Only 50% have fever
  • Older infants, toddlers, children
    • Fever (>101.3), localizing signs
  • Labs
    • CRP >20
    • WBC >12K

Differential Diagnosis

Evaluation

Work-Up

  • Labs
    • CBC, ESR, CRP, , blood/throat cultures
  • Arthrocentesis
    • Cell count, gram stain, glucose, cultures

Kocher Criteria

  • One point each
    • Non-weight bearing on affected side
    • ESR >40mm/hr
    • Fever
    • WBC >12,000
  • Probability by points[1]
    • 1 of 4 - 3%
    • 2 of 4 - 40%
    • 3 of 4 - 93%
    • 4 of 4 - 99%

Management

  1. Joint drainage/wash out
  2. IV antibiotics
Age Suspected Organism Antibiotics
Newborn (0–2 mo) Staphylococcus aureus Vancomycin, 10 milligrams/kg every 6–8 h
or 
Clindamycin, 10 milligrams/kg every 6–8 h
Group B Streptococcus Ampicillin, 50–100 milligrams/kg every 6 h
and 
Cefotaxime, 50 milligrams/kg every 6–8 h
or 
Ceftriaxone, 50 milligrams/kg every 12 h
Gram-negative bacilli Cefotaxime, 50 milligrams/kg every 8 h
Neisseria gonorrhoeae  Cefotaxime, 50 milligrams/kg every 8 h
Unknown Vancomycin or clindamycin and cefotaxime or ceftriaxone (dosing as above)
Infant (2–36 mo) S. aureus Vancomycin or clindamycin (dosing as above)
Streptococcus species Clindamycin/cefotaxime/ceftriaxone (dosing as above)
Gram-Negative bacilli Cefotaxime or ceftriaxone (dosing as above)
Haemophilus influenzae  Cefotaxime or ceftriaxone (dosing as above)
Unknown Vancomycin or clindamycin and cefotaxime or ceftriaxone
Child (>36 mo) S. aureus Vancomycin or clindamycin
Streptococcus species  Clindamycin/cefotaxime/ceftriaxone
Gram-negative bacilli Cefotaxime or ceftriaxone
N. gonorrhoeae Cefotaxime or ceftriaxone
Unknown Vancomycin or clindamycin and cefotaxime or ceftriaxone

Disposition

  • Admit

See Also

References

  1. Kocher, MS, et al. Differentiating between septic arthritis and transient synovitis of the hip in children: an evidence-based clinical prediction algorithm. J Bone Joint Surg Am. 1999; 81 (12):1662–70.